JPH05337151A - Wound cover material - Google Patents
Wound cover materialInfo
- Publication number
- JPH05337151A JPH05337151A JP4151937A JP15193792A JPH05337151A JP H05337151 A JPH05337151 A JP H05337151A JP 4151937 A JP4151937 A JP 4151937A JP 15193792 A JP15193792 A JP 15193792A JP H05337151 A JPH05337151 A JP H05337151A
- Authority
- JP
- Japan
- Prior art keywords
- film
- wound
- support layer
- water
- adhesive layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 28
- 239000010410 layer Substances 0.000 claims abstract description 24
- 239000012790 adhesive layer Substances 0.000 claims abstract description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 10
- 239000005871 repellent Substances 0.000 claims abstract description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 9
- 239000012528 membrane Substances 0.000 claims description 25
- 239000004745 nonwoven fabric Substances 0.000 claims description 15
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 abstract description 15
- 229910021536 Zeolite Inorganic materials 0.000 abstract description 14
- 239000010457 zeolite Substances 0.000 abstract description 14
- 108010035532 Collagen Proteins 0.000 abstract description 13
- 102000008186 Collagen Human genes 0.000 abstract description 13
- 229920001436 collagen Polymers 0.000 abstract description 13
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 230000035876 healing Effects 0.000 abstract description 5
- 208000035143 Bacterial infection Diseases 0.000 abstract description 4
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000004744 fabric Substances 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 description 47
- 239000010408 film Substances 0.000 description 24
- -1 polytetrafluoroethylene Polymers 0.000 description 13
- 239000000126 substance Substances 0.000 description 11
- 239000004743 Polypropylene Substances 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 210000000416 exudates and transudate Anatomy 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229920001155 polypropylene Polymers 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 229920002635 polyurethane Polymers 0.000 description 7
- 239000004814 polyurethane Substances 0.000 description 7
- 229940105329 carboxymethylcellulose Drugs 0.000 description 6
- 229910021645 metal ion Inorganic materials 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000010559 graft polymerization reaction Methods 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 244000309715 mini pig Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000003484 crystal nucleating agent Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003176 fibrotic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229920006268 silicone film Polymers 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- ZKVMMSGRDBQIOQ-UHFFFAOYSA-N 1,1,2-trichloro-1-fluoroethane Chemical compound FC(Cl)(Cl)CCl ZKVMMSGRDBQIOQ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 229960002028 atropine sulfate Drugs 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- 229950003616 azaperone Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940105631 nembutal Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、創傷被覆材に関する。FIELD OF THE INVENTION The present invention relates to a wound dressing.
【0002】[0002]
【従来の技術】熱傷、採皮創および皮膚剥削創、外傷性
皮膚欠損創等の疾患ないし創傷による患部を保護し、治
癒を促進する目的のために、患部に一時的に適応される
創傷被覆材として、従来、ガーゼ、脱脂綿等が用いられ
てきたが、これらは細菌感染防止が低く、かつ滲出液を
速やかに吸収するために創面が乾燥してしまうと取り外
す際に、痛み、出血等を伴った。2. Description of the Related Art A wound coating temporarily applied to an affected area for the purpose of protecting the affected area due to a disease or a wound such as a burn, a skin-extracting wound and a skin-exfoliating wound, and a traumatic skin defect wound, and promoting healing. Conventionally, gauze, absorbent cotton, etc. have been used as materials, but these have low bacterial infection prevention, and when the wound surface is dry to absorb exudate quickly, it causes pain, bleeding, etc. when removed. Accompanied.
【0003】また、軟膏等を併用することも行われてい
るが、この場合は逆に滲出液の吸収が不充分で創面が過
度に湿った状態になってしまうものであった。Further, an ointment or the like is also used in combination, but in this case, on the contrary, the absorption of the exudate is insufficient and the wound surface becomes excessively wet.
【0004】また、これらに代わるものとしては、特に
創面が広範囲にわたる場合に適用されるものとして、シ
リコーン製ガーゼ、シリコーンゴム製およびベロアー状
の表面構造を有するナイロン、テフロンなど合成樹脂シ
ート等の人工材料の被覆膜や凍結乾燥豚皮、キチン不織
布、コラーゲン膜、ポリアミノ酸スポンジ、ムコ多糖複
合コラーゲン膜等の生体由来材料の被覆膜も知られてい
る。As an alternative to these, particularly when applied to a wide range of wound surfaces, artificial synthetic resin sheets such as silicone gauze, silicone rubber and nylon and teflon having a velor-like surface structure are used. A coating film of a material and a coating film of a bio-derived material such as freeze-dried pig skin, chitin nonwoven fabric, collagen film, polyamino acid sponge, mucopolysaccharide complex collagen film are also known.
【0005】しかしながら、これらのうち人工材料の被
覆膜は、患部との密着性、水蒸気透過性、ひび割れなど
の点で種々の問題点を残し、一方生体由来材料の被覆膜
は生体適合性が良いなどの特徴を有するが、その多くは
抗原性を有し、また細菌感染、滲出液による劣化などの
欠点を有し、さらに材料が入手しにくい等の問題があっ
た。However, among these, the coating film of the artificial material leaves various problems in terms of adhesion to the affected area, water vapor permeability, cracking, etc., while the coating film of the biological material is biocompatible. However, many of them have antigenicity, and also have drawbacks such as bacterial infection and deterioration due to exudate, and there is a problem that the material is difficult to obtain.
【0006】さらに最近では、コラーゲン処理したナイ
ロンメッシュとシリコーン膜からなる複合膜が開発され
実用化されており、よく密着し、適度な水分透過性を有
するが、創面に固着し、肉芽組織が被覆膜中に入り込む
という欠点があった。また、滲出液が多量に出る創面に
適用した場合、シリコーン膜下のナイロンメッシュ中に
滲出液が貯留して感染することがあるため、最近ではシ
リコーン膜に意図的に穴を空けるなどの処理がされてい
る。More recently, a composite membrane consisting of a collagen-treated nylon mesh and a silicone membrane has been developed and put into practical use. Although it adheres well and has an appropriate water permeability, it adheres to the wound surface and the granulation tissue is covered. There was a drawback that it penetrated into the covering film. In addition, when applied to a wound surface where a large amount of exudate is produced, the exudate may accumulate in the nylon mesh under the silicone film and become infected, so recently treatments such as intentionally making holes in the silicone film have become necessary. Has been done.
【0007】[0007]
【発明が解決しようとする課題】熱傷等により皮膚組織
が損失した場合の患部に対する処理としては、自家移植
が現在最善の方法とされているが、皮膚欠損部が広範囲
にわたる場合においては非常に困難であり、適用可能で
あっても長期間にわたって幾度となく移植を繰り返す必
要がある。従って自家移植に代わって患部を一時的また
は永続的に被覆して細菌感染及び体液の流出を防止し、
かつ組織の修復を促進するような創傷被覆材の開発が望
まれる。Autologous transplantation is currently the best method for treating the affected area when skin tissue is lost due to burns or the like, but it is very difficult when the skin defect area is wide. Therefore, even if it is applicable, it is necessary to repeat transplantation repeatedly over a long period of time. Therefore, instead of autologous transplantation, the affected area is temporarily or permanently covered to prevent bacterial infection and body fluid outflow,
Moreover, the development of a wound dressing that promotes tissue repair is desired.
【0008】[0008]
【課題を解決するための手段】上記目的は下記の構成を
有する本発明の創傷被覆材によって達成される。 (1)撥水性物質により被覆されたカルボキシメチルセ
ルロース不織布からなる支持層、接着剤層及び親水性多
孔質膜が積層された膜からなり、更に当該積層された膜
に直径1〜3mm径の貫通孔が設けられていることを特徴
とする創傷被覆材。 (2)前記支持層及び前記接着剤層の少なくともいずれ
か一方が抗菌性ゼオライトを含有していることを特徴と
する(1)に記載の創傷被覆材。 (3)前記支持層にコラーゲンが被覆されていることを
特徴とする(1)及び(2)に記載の創傷被覆材。The above object can be achieved by the wound dressing of the present invention having the following constitution. (1) A support layer made of a carboxymethyl cellulose nonwoven fabric coated with a water-repellent material, an adhesive layer, and a membrane in which a hydrophilic porous membrane is laminated, and the through-membrane having a diameter of 1 to 3 mm is further formed in the laminated membrane. A wound dressing characterized by being provided. (2) The wound dressing material according to (1), wherein at least one of the support layer and the adhesive layer contains antibacterial zeolite. (3) The wound dressing material according to (1) or (2), wherein the support layer is coated with collagen.
【0009】本発明の創傷被覆材は上記のように高含水
ゲル形成性物質膜層からなるカルボキシメチルセルロー
ス不織布の支持層,接着剤層及び親水性多孔質膜層の3
層からなる。As described above, the wound dressing of the present invention comprises a support layer of a carboxymethyl cellulose nonwoven fabric comprising a highly hydrous gel-forming substance membrane layer, an adhesive layer and a hydrophilic porous membrane layer.
Consists of layers.
【0010】前記高含水ゲル形成性物質薄膜により形成
された撥水処理したカルボキシメチルセルロース不織布
の支持層は、水分保持、吸水性を持つことにより、滲出
液の適度の貯留機能と創面への良好な密着性かつ非癒着
性を有し、この性質及び上記材質の持つ生体に不活性な
性質により疼痛抑制作用を有する。このため高含水状態
による適正な生体環境が維持され、治癒、特に表皮再生
が促進され、更に創面への良好な密着性を有することに
より、細菌の創面への侵入を抑制する。The support layer of the water-repellent carboxymethylcellulose nonwoven fabric formed of the thin film of a highly hydrous gel-forming substance has a water-retaining property and a water-absorbing property, so that it has an appropriate storage function for exudate and a good function on the wound surface. It has adhesiveness and non-adhesiveness, and has a pain-suppressing action due to this property and the inactive property of the above-mentioned material on the living body. Therefore, an appropriate biological environment due to the high water content state is maintained, healing, especially epidermal regeneration is promoted, and further, good adhesion to the wound surface is provided, thereby suppressing the invasion of bacteria to the wound surface.
【0011】前記撥水性物質は、シリコーン、ポリウレ
タン、スチレン−ブタジエン−スチレンブロックコポリ
マー及びポリテトラフルオロエチレンからなる群から選
ばれたものであることが好ましい。The water-repellent material is preferably selected from the group consisting of silicone, polyurethane, styrene-butadiene-styrene block copolymer and polytetrafluoroethylene.
【0012】多孔質膜はポリエチレン、ポリプロピレン
のようなポリオレフィンまたはポリフッ化ビニリデン、
ポリ塩化ビニリデン、塩素化ポリエチレンのようなハロ
ゲン化ポリオレフィンまたはこれらの混合物で形成され
る。The porous membrane may be a polyolefin such as polyethylene or polypropylene, or polyvinylidene fluoride,
It is formed of polyvinylidene chloride, a halogenated polyolefin such as chlorinated polyethylene, or a mixture thereof.
【0013】前記親水性多孔質膜は多孔質膜の表面を化
学的結合より被覆するポリマーであれば特に限定はない
が、好ましい例としてはポリメトキシエチルアクリレー
ト、ポリジメチルアクリルアミド、メトキシアクリル酸
エステル共重合体、ジメチルアクリルアミド共重合体が
あげられる。多孔質膜は孔径0.01〜1.0μm、水蒸
気透過率(JIS規格)は500〜5000g/m22
4hrであることが好ましい。The hydrophilic porous membrane is not particularly limited as long as it is a polymer that coats the surface of the porous membrane by chemical bonding, but preferred examples include polymethoxyethyl acrylate, polydimethylacrylamide and methoxyacrylic acid ester. Examples thereof include polymers and dimethylacrylamide copolymers. The porous membrane has a pore size of 0.01 to 1.0 μm and a water vapor transmission rate (JIS standard) of 500 to 5000 g / m 2 2.
It is preferably 4 hr.
【0014】また、本発明の創傷被覆材は直径1〜3mm
径の貫通孔を設けることにより、物質透過が容易にな
り、特に滲出液の過度の貯留に対してはこれを排液する
ことにより血腫等の形成を防ぐことができる。The wound dressing of the present invention has a diameter of 1 to 3 mm.
By providing a through hole having a diameter, the substance can be easily permeated, and particularly when the exudate is excessively stored, drainage of the exudate can prevent the formation of a hematoma or the like.
【0015】本発明は特に外部からの感染に対しては、
接着剤層あるいは支持層のいずれか一方に抗菌性ゼオラ
イトが含有することが好ましい。The present invention particularly relates to external infections,
It is preferable that the antibacterial zeolite is contained in either the adhesive layer or the support layer.
【0016】本発明で使用される抗菌性ゼオライトの母
体となっているゼオライトは、三次元的に発達した骨格
構造を有するアルカリ又は、アルカリ土類金属のアミノ
ケイ酸塩である。The zeolite, which is the matrix of the antibacterial zeolite used in the present invention, is an alkali or alkaline earth metal aminosilicate having a three-dimensionally developed skeleton structure.
【0017】その一般式は、XMa・O・Al2O3・y
SiO2・zH2Oで表される(M=金属イオン、X=金
属酸化物の係数、a=2Xn-1(n=金属の原子価)、
y=シリカの係数、z=結合水の分子量)。The general formula is XM a · O · Al 2 O 3 · y
Represented by SiO 2 · zH 2 O (M = metal ion, X = coefficient of metal oxide, a = 2Xn −1 (n = valence of metal),
y = coefficient of silica, z = molecular weight of bound water).
【0018】本発明に用いる抗菌性ゼオライトは、ゼオ
ライトの陽イオン交換能を利用し、抗菌性金属イオンを
ゼオライト母体中に保有された抗菌性金属イオン含有ゼ
オライトである。抗菌性金属イオンとしては、銀、銅、
亜鉛があり、外科用ドレッシングとして使用する場合
は、銀を使用することが好ましいが、更に好ましくは亜
鉛や銅などを含む複数の金属を用いるのが良い。The antibacterial zeolite used in the present invention is an antibacterial metal ion-containing zeolite in which the cation exchange ability of zeolite is utilized and antibacterial metal ions are retained in the zeolite matrix. Antibacterial metal ions include silver, copper,
There is zinc, and when it is used as a surgical dressing, it is preferable to use silver, but it is more preferable to use a plurality of metals including zinc and copper.
【0019】ゼオライト母体及び抗菌性金属(銅、亜
鉛)の化合物は、米国の食品医薬局(FDA)にて食品
添加として認められている。また、抗菌性金属イオン
は、ゼオライト母体中に保持されているので、微量に溶
出する抗菌性金属イオンは拡散により長期間徐放し続け
ることができる。The compound of the zeolite matrix and the antibacterial metal (copper, zinc) is approved as a food additive by the US Food and Drug Administration (FDA). Further, since the antibacterial metal ion is retained in the zeolite matrix, the minute amount of the antibacterial metal ion eluted can be gradually released for a long time by diffusion.
【0020】さらに本発明の創傷被覆材は、支持層にコ
ラーゲンを被覆することにより、創傷面における止血を
容易にする。Furthermore, the wound dressing of the present invention facilitates hemostasis on the wound surface by coating the support layer with collagen.
【0021】本発明で使用する原料はコラーゲン、酸ま
たはアルカリ処理したコラーゲンをさらにプロクターゼ
またはペプシンによりその分子末端のテロペプチドを消
化除去し、抗原性を無くしたものが好ましい。更に、本
発明で使用するコラーゲンは止血効果を促進させるため
に、分散状コラーゲンを37℃でりん酸系の緩衝液を用
いて中和処理し、生体内にあるような周期性を線維構造
をもつ再構成された線維化コラーゲンの形にすることが
好ましい。The raw material used in the present invention is preferably collagen, acid- or alkali-treated collagen, which is further digested to remove the telopeptide at the molecular end thereof with proctase or pepsin to eliminate the antigenicity. Furthermore, in order to promote the hemostatic effect, the collagen used in the present invention is neutralized at a temperature of 37 ° C. with a phosphate-based buffer solution to form a periodic fibrous structure with a periodicity like in vivo. It is preferably in the form of reconstituted fibrotic collagen.
【0022】本発明に用いる接着剤としては、カルボキ
シメチルセルロース不織布と親水性多孔質膜との接着性
が良く、水蒸気透過性を有する等の必要性からポリウレ
タン系の接着剤が好ましい。As the adhesive used in the present invention, a polyurethane-based adhesive is preferable because it is required to have good adhesiveness between the carboxymethyl cellulose nonwoven fabric and the hydrophilic porous membrane and to have water vapor permeability.
【0023】本発明の創傷被覆材は例えば次のようにし
て製造される。まずポリプロピレン粉末に所定量の流動
パラフィン及び結晶核形成剤を加えて溶融混練しペレッ
ト化する。このペレットを150〜200℃で溶融し、
Tダイ付の押出機により押出し、冷却固定化してフィル
ムにし、該フィルム中の流動パラフィンの抽出を行な
い、135℃程度の空気中で約2分間熱処理を行ない、
ポリプロピレン製の多孔質膜を得る。該膜にメトキシエ
チルアクリレートをプラズマ開始表面グラフト重合し、
親水化処理したポリプロピレン製多孔質膜を得る。The wound dressing of the present invention is manufactured, for example, as follows. First, a predetermined amount of liquid paraffin and a crystal nucleating agent are added to polypropylene powder, melt-kneaded and pelletized. Melt the pellets at 150-200 ° C.,
Extruded by an extruder with T-die, cooled and fixed to form a film, liquid paraffin in the film is extracted, and heat-treated in air at about 135 ° C. for about 2 minutes,
A polypropylene porous film is obtained. Plasma-initiated surface graft polymerization of methoxyethyl acrylate onto the film,
A hydrophilic polypropylene porous membrane is obtained.
【0024】創傷被覆材を作製するに際し、まず生体適
合性を有する高含水ゲル形成性物質であるカルボキシメ
チルセルロース不織布を準備する。上記基材に線維化ア
テロコラーゲンを被覆したのち乾燥させ、撥水性物質、
例えばシリコーン、ポリウレタン、スチレン−ブタジエ
ン−スチレンブロックコポリマー、ポリテトラフルオロ
エチレンをヘキサン、テトラヒドロフラン、メチルエチ
ルケトンに1〜10重量%程度溶解した撥水性物質溶液
を作製し、高含水ゲル形成性物質を作成し、高含水ゲル
形成性物質薄膜をこの溶液に浸漬、またはスプレー、ロ
ーラーなどを用いて塗布することにより得られる。次に
テフロン上にポリウレタン接着剤溶液を延展して製膜
し、該接着剤層が未だ粘着性を有する状態において、上
記の段階で得られた撥水処理してコラーゲンを被覆した
カルボキシメチルセルロース不織布を上面の面が接着剤
層に付着するように載置し、乾燥し、更に必要に応じて
熱処理を30分程施し、硬化させて支持層の上方の面に
接着剤層を付着させる。In producing the wound dressing, first, a carboxymethyl cellulose nonwoven fabric, which is a biocompatible, highly hydrous gel-forming substance, is prepared. After coating the above-mentioned base material with fibrotic atelocollagen and drying, a water-repellent substance,
For example, a water-repellent substance solution in which silicone, polyurethane, styrene-butadiene-styrene block copolymer, polytetrafluoroethylene is dissolved in hexane, tetrahydrofuran, or methyl ethyl ketone at about 1 to 10% by weight to prepare a highly hydrous gel-forming substance, It can be obtained by dipping a thin film of a highly hydrous gel-forming substance in this solution, or by applying it with a spray, a roller or the like. Next, a polyurethane adhesive solution is spread on Teflon to form a film, and in a state where the adhesive layer is still tacky, the water-repellent treated collagen-coated carboxymethylcellulose nonwoven fabric obtained in the above step is obtained. The adhesive layer is placed so that the upper surface adheres to the adhesive layer, dried, and optionally subjected to heat treatment for about 30 minutes and cured to adhere the adhesive layer to the upper surface of the support layer.
【0025】最後に、接着剤層が付着された高含水ゲル
形成性を有する支持層に、親水処理したポリプロピレン
製の多孔質膜をラミネートすると所望の創傷被覆材を得
ることができる。Finally, a desired wound dressing can be obtained by laminating a hydrophilic membrane made of polypropylene on a support layer having a high water content gel forming property to which an adhesive layer is attached.
【0026】[0026]
(実施例1) 親水性多孔質膜の作製(1) メルトフローインデックスが30及び0.3のポリプロ
ピレン混合物(混合物(混合重量比100:40)10
0重量部当り、400重量部の流動パラフィン(平均分
子量324)及び0.3重量部の結晶核形成剤としての
1,3,2,4−ビス(p−エチルベンジリデン)ソル
ビトールを二軸型押出機により溶融混練し、ペレット化
した。このペレットを上記二軸型押出機を用いて150
〜200℃で溶融し、スリット0.6mmのTダイより空気
中に押出しフィルム状にし、このフィルム状物をTダイ
値下に置かれたガイドローラーによって冷却固定化液中
に導き冷却固定化した後巻取る。この巻取ったフィルム
状物を一定寸法に切断し、縦横両方を固定し、1,1,
2−トリクロロ−1,2,2−トリフルオロエタン中に
10分間計4回浸漬して、フィルム状物中の流動パラフ
ィンの抽出を行う。孔径0.6μm、膜厚140μmの
ポリプロピレン製多孔質膜を得た。(Example 1) Preparation of hydrophilic porous membrane (1) Polypropylene mixture having a melt flow index of 30 and 0.3 (mixture (mixing weight ratio 100: 40) 10
Biaxial extrusion of 0,400 parts by weight of liquid paraffin (average molecular weight 324) and 0.3 parts by weight of 1,3,2,4-bis (p-ethylbenzylidene) sorbitol as a crystal nucleating agent. It was melt-kneaded by a machine and pelletized. The pellets were mixed with the above twin-screw extruder for 150
It was melted at ~ 200 ° C and extruded into air from a T-die having a slit of 0.6 mm to form a film, and this film-like material was introduced into a cooling-immobilizing liquid by a guide roller placed below the T-die value and cooled and immobilized. After winding. This wound film-like material is cut into a certain size, fixed in both length and width, 1,1,
Liquid paraffin is extracted from the film-like material by immersing it in 2-trichloro-1,2,2-trifluoroethane for a total of four times for 10 minutes. A polypropylene porous film having a pore size of 0.6 μm and a film thickness of 140 μm was obtained.
【0027】この膜にメトキシエチルアクリレートをプ
ラズマ開始表面グラフト重合し、親水処理した多孔質膜
を得た。即ち、PP膜に0.1トール、15秒でアルゴ
ンプラズマを照射した後、メトキシエチルアクリレート
雰囲気中で(25℃、4トール)、30分グラフト重合
を行った。Plasma-initiated surface graft polymerization of methoxyethyl acrylate was performed on this film to obtain a hydrophilically treated porous film. That is, the PP film was irradiated with argon plasma at 0.1 Torr for 15 seconds, and then graft polymerization was performed for 30 minutes in a methoxyethyl acrylate atmosphere (25 ° C., 4 Torr).
【0028】(実施例2) 親水性多孔質膜の作製(2) ポリフッ化ビニリデン粉末(三菱油化(株)製)Kyn
ar K301 18重量部をアセトン73.8重量部
及びジメチルホルムアミド8.2重量部に溶解してなる
溶液を、ポリエチレンテレフタレートフィルム上にキャ
ストした後、1,1,2−トリクロロフルオロエタン浴
中に5分間浸漬して平均孔径0.45μm、膜厚135μ
mのポリフッ化ビニリデン多孔質膜を得た。(Example 2) Preparation of hydrophilic porous membrane (2) Polyvinylidene fluoride powder (manufactured by Mitsubishi Petrochemical Co., Ltd.) Kyn
ar K301 (18 parts by weight) dissolved in acetone (73.8 parts by weight) and dimethylformamide (8.2 parts by weight) was cast on a polyethylene terephthalate film, and the solution was added to a 1,1,2-trichlorofluoroethane bath to give 5 parts. Dipping for a minute, average pore size 0.45μm, film thickness 135μ
m of polyvinylidene fluoride porous film was obtained.
【0029】この膜にメトキシエチルアクリレートをプ
ラズマ開始表面グラフト重合し、親水処理した多孔質膜
を得た。A plasma-initiated surface graft polymerization of methoxyethyl acrylate was performed on this membrane to obtain a hydrophilically treated porous membrane.
【0030】(実施例3) 創傷被覆材の作製(1) 市販のカルボキシメチルセルロースナトリウム塩製の不
織布(東海染工(株)製、エーテル化度0.40)を5
%のメディカルグレードサイラスティックス−シリコー
ン(接着シリコーンタイプA、ダウコーニング(株)
製)のヘキサン溶液中に10秒間浸漬した後、クリーン
ベンチ内で乾燥させた。次に剥離紙上に60%ポリウレ
タン製接着剤(ハイムレンY−199(E)、大日精化
(株)製)を精密被覆用具(アプリケーター)を用いて
塗布し製膜し、塗布した直後に、その湿潤層上に上記の
不織布を載せ、室温で10分間放置した後80℃で少な
くとも1時間、オーブンで硬化させた。更に上記で得ら
れた親水処理したポリプロピレン製の多孔質膜を裏打ち
して乾燥し、1mm径のポンチで一定の間隔で打抜くこと
により創傷被覆材を得ることができた。Example 3 Preparation of Wound Dressing (1) A commercially available non-woven fabric of carboxymethyl cellulose sodium salt (manufactured by Tokai Senko Co., Ltd., etherification degree: 0.40) was used.
% Medical grade silastics-silicone (adhesive silicone type A, Dow Corning Co., Ltd.)
It was dipped in a hexane solution (made by Mitsui Chemical Co., Ltd.) for 10 seconds and then dried in a clean bench. Next, a 60% polyurethane adhesive (Heimren Y-199 (E), manufactured by Dainichiseika Co., Ltd.) was applied on a release paper using a precision coating tool (applicator) to form a film, and immediately after the application, The above nonwoven fabric was placed on the wet layer, left at room temperature for 10 minutes, and then cured in an oven at 80 ° C. for at least 1 hour. Further, the wound-dressing material could be obtained by backing and drying the hydrophilic polypropylene-made porous membrane obtained above and punching it with a 1 mm diameter punch at regular intervals.
【0031】(実施例4) 創傷被覆材(2) 上記と同様な方法でシリコーン処理したカルボキシメチ
ルセルロースナトリウム塩製の不織布を調製する。次に
剥離紙上に60%ポリウレタン製接着剤に抗菌性ゼオラ
イト(Ag,Znゼオライト、ニチメン(株)製)を分
散させた粘調溶液をアプリケーターを用いて塗布し製膜
し、塗布した直後にその湿潤層上に上記の不織布を載
せ、室温で10分間放置した後、80℃で少なくとも1
時間オーブンで硬化させた。含有するAg,Znゼオラ
イト量は約0.69mg/不織布cm2であった。更に上
記で得られた親水処理したポリプロピレン製の多孔質膜
(あるいは親水処理したポリフッ化ビニリデン製の多孔
質膜)を裏打ちし、1mm径の直径のポンチで一定の間
隔で打抜くことにより創傷被覆材を得ることができた。Example 4 Wound Dressing Material (2) A non-woven fabric made of carboxymethyl cellulose sodium salt treated with silicone is prepared in the same manner as above. Next, a viscous solution in which an antibacterial zeolite (Ag, Zn zeolite, manufactured by Nichimen Co., Ltd.) was dispersed on a release paper made of 60% polyurethane was applied using an applicator to form a film, and immediately after the application, Place the above non-woven fabric on the wetting layer, leave it at room temperature for 10 minutes, and then at least 1 hour at 80 ° C.
Cured in oven for hours. The amount of Ag and Zn zeolite contained was about 0.69 mg / cm 2 of non-woven fabric. Furthermore, wound-covering is performed by lining the hydrophilically-treated polypropylene porous membrane (or hydrophilically-treated polyvinylidene fluoride porous membrane) obtained above and punching the punches with a diameter of 1 mm at regular intervals. I was able to obtain wood.
【0032】(実施例5) 創傷被覆材(3) アテロコラーゲン(高研(株)製)を4℃の温度下でp
H3.0の希塩酸に溶解して0.3w/v%に調製した。
4℃に維持しつつ攪拌しながらpH7.4のりん酸緩衝液を
加え、最終濃度が0.1w/v%であるコラーゲン溶液
とした。次にカルボキシメチルセルロースナトリウム塩
製の不織布に上記で調製したコラーゲン溶液を被覆し
て、37℃のインキュベーター内に4時間乾燥した後、
クリーンベンチで乾燥した。更に5%のメディカルグレ
ードサイラスティック−スシリコーンのヘキサン溶液中
に10秒間浸漬した後、クリーンベンチ内で乾燥した。Example 5 Wound Dressing Material (3) Atelocollagen (manufactured by Koken Co., Ltd.) was added at a temperature of 4 ° C.
It was dissolved in dilute hydrochloric acid of H3.0 to prepare 0.3 w / v%.
A pH 7.4 phosphate buffer was added while stirring at 4 ° C. to give a collagen solution having a final concentration of 0.1 w / v%. Next, a non-woven fabric made of sodium carboxymethyl cellulose is coated with the collagen solution prepared above and dried in an incubator at 37 ° C. for 4 hours.
Dried on a clean bench. Further, it was immersed in a hexane solution of 5% medical grade silastic silicone for 10 seconds, and then dried in a clean bench.
【0033】次に剥離紙上に60%ポリウレタン製接着
剤をアプリケーターを用いて塗布し製膜し、塗布した直
後に、その湿潤層上に上記の不織布を載せ、室温で10
分間放置した後、80℃で少なくとも1時間オーブンで
硬化させた。更に上記で得られた親水処理したポリプロ
ピレン製の多孔質膜を裏打ちして乾燥し、1mm径の直径
のポンチで一定間隔で打抜くことにより創傷被覆材を得
ることができた。Next, a 60% polyurethane adhesive was applied onto a release paper using an applicator to form a film, and immediately after the application, the above-mentioned non-woven fabric was placed on the wet layer and the temperature was maintained at room temperature for 10 minutes.
After standing for a minute, it was cured in an oven at 80 ° C. for at least 1 hour. Further, the wound-dressing material could be obtained by backing and drying the hydrophilic polypropylene-made porous membrane obtained above and punching it with a punch having a diameter of 1 mm at regular intervals.
【0034】(実施例6) 創傷被覆材のミニブタ皮膚欠損創への移植実験 実施例1〜3で得られた創傷被覆材をミニブタの背部皮
膚に移植して試験した。ユカタンマイクロブタ(10〜
15kg)を硫酸アトロピン0.05mg/kg、アザペロン
2mg/kgを前投与後(血中下)、10〜15分経過した
後ケタミン15mg/kg(血中下)で導入した。更にネン
ブタール10mg/kg(皮下)で維持麻酔を行った。麻酔
を施した後、ミニブタの背部皮膚を広範囲に剃毛し術野
とした。消毒を綿密におこない背部中央に3×3cmの大
きさの採皮層(10/1000インチ)をデルマトーム
により作製し、創傷被覆材を創傷部に載せ、その上に非
癒着性被覆材(プリマポア スミス アンド ネフュー
製)を載せて、その上を更に伸縮性のインサイドドレー
プ(スデ)ドレープ,スリーエス(株)製)で覆った
後、伸縮テープを用いて固定した。3および14日後に
治癒の状態を観察した。Example 6 Experiment of Transplanting Wound Dressing on Mini Pig Skin Defect Wound The wound dressing obtained in Examples 1 to 3 was transplanted to the dorsal skin of a mini pig and tested. Yucatan micro pig (10
15 kg) was pre-administered with atropine sulfate (0.05 mg / kg) and azaperone (2 mg / kg) (in blood), and after 10 to 15 minutes, ketamine (15 mg / kg (in blood)) was introduced. Furthermore, maintenance anesthesia was performed with Nembutal 10 mg / kg (subcutaneous). After anesthesia, the dorsal skin of the miniature pig was extensively shaved and used as the surgical field. After sterilizing thoroughly, a skin layer of 3 × 3 cm (10/1000 inch) was prepared in the center of the back by a dermatome, the wound dressing was placed on the wound, and the non-adhesive dressing (Primapore Smith and (Made by Nephew) was placed thereon, and the inside was further covered with a stretchable inside drape (Sude) drape, manufactured by 3S Co., Ltd., and then fixed using a stretch tape. The state of healing was observed after 3 and 14 days.
【0035】3日目ではいずれの被覆材もよく密着して
おり、貫通孔はほとんど血液でふさがっていた。14日
後では、表皮が再生されており、被覆材も容易に創面か
らはがすことができた。On the third day, all the coating materials were in close contact with each other, and the through holes were almost filled with blood. After 14 days, the epidermis was regenerated and the covering material could be easily peeled off from the wound surface.
【0036】[0036]
【発明の効果】本発明の創傷被覆材は、創傷部に接触し
得る部位が撥水性物質により被覆された生体適合性を有
する高含水ゲル形成性物質薄膜により形成された支持
層、接着剤創と親水性多孔質膜とが積層されており、更
に貫通孔を有しているので、熱傷、採皮創及び皮膚剥削
創、外傷性皮膚欠損創等の疾患ないし創傷による患部に
適用された際に、被覆材下に滲出液や血液が貯留するこ
となく密着して感染、痛みを防ぎ、また創面との接触部
位は生体適合性を有するので、該被覆材が創面に固着し
てしまい剥離時に出血,痛み等を伴うといったことも起
こらず、創傷部の治癒を促進し、かつ瘢痕を残すことな
くきれいに再生することができる。EFFECTS OF THE INVENTION The wound dressing of the present invention comprises a support layer and an adhesive layer formed of a biocompatible highly water-containing gel-forming substance thin film in which a site that can come into contact with a wound is coated with a water-repellent substance. And a hydrophilic porous membrane are laminated, and since they have through holes, when applied to the affected area due to a disease such as a burn, a skin-wound and a skin-exfoliated wound, a traumatic skin defect wound, or a wound. In addition, since the exudate or blood does not accumulate under the covering material and adheres closely to prevent infection and pain, and the contact site with the wound surface has biocompatibility, the covering material sticks to the wound surface and peels off. It does not cause bleeding, pain, etc., promotes healing of the wound, and can be regenerated cleanly without leaving a scar.
Claims (1)
メチルセルロース不織布からなる支持層、接着剤層及び
親水性多孔質膜が積層された積層構造体であって、かつ
当該積層構造体に直径1〜3mm径の貫通孔が設けられて
いることを特徴とする創傷被覆材。1. A laminated structure in which a support layer made of a carboxymethyl cellulose nonwoven fabric coated with a water-repellent material, an adhesive layer, and a hydrophilic porous membrane are laminated, and the laminated structure has a diameter of 1 to 3 mm. A wound dressing characterized by having a through hole of a diameter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4151937A JPH05337151A (en) | 1992-06-11 | 1992-06-11 | Wound cover material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4151937A JPH05337151A (en) | 1992-06-11 | 1992-06-11 | Wound cover material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH05337151A true JPH05337151A (en) | 1993-12-21 |
Family
ID=15529467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4151937A Pending JPH05337151A (en) | 1992-06-11 | 1992-06-11 | Wound cover material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH05337151A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009525795A (en) * | 2006-02-09 | 2009-07-16 | ストライカー トラウマ ゲーエムベーハー | Medical adhesives and hemostats |
| FR2971971A1 (en) * | 2011-02-24 | 2012-08-31 | Zodiac Automotive Division | Composite material, useful in a medical device for protecting a skin area such as dressing, comprises a layer of a non-woven material comprising hydrocolloid fibers and layer comprising a silicone |
| EP3470092A4 (en) * | 2016-06-14 | 2020-02-12 | Tokuyama Corporation | PROTECTIVE MATERIAL FOR LIVESTOCK, KIT FOR FORMING A PROTECTIVE FILM FOR LIVESTOCK AND METHOD FOR PROTECTING SICK / INJURED AREAS IN LIVESTOCK |
| JP2020065849A (en) * | 2018-10-26 | 2020-04-30 | 国立研究開発法人農業・食品産業技術総合研究機構 | Hydrogel membrane and its use |
-
1992
- 1992-06-11 JP JP4151937A patent/JPH05337151A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009525795A (en) * | 2006-02-09 | 2009-07-16 | ストライカー トラウマ ゲーエムベーハー | Medical adhesives and hemostats |
| US8440209B2 (en) | 2006-02-09 | 2013-05-14 | Stryker Trauma Gmbh | Adhesive for medical applications and means for haemostasis |
| FR2971971A1 (en) * | 2011-02-24 | 2012-08-31 | Zodiac Automotive Division | Composite material, useful in a medical device for protecting a skin area such as dressing, comprises a layer of a non-woven material comprising hydrocolloid fibers and layer comprising a silicone |
| EP3470092A4 (en) * | 2016-06-14 | 2020-02-12 | Tokuyama Corporation | PROTECTIVE MATERIAL FOR LIVESTOCK, KIT FOR FORMING A PROTECTIVE FILM FOR LIVESTOCK AND METHOD FOR PROTECTING SICK / INJURED AREAS IN LIVESTOCK |
| JP2020065849A (en) * | 2018-10-26 | 2020-04-30 | 国立研究開発法人農業・食品産業技術総合研究機構 | Hydrogel membrane and its use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0475807B1 (en) | Wound-covering materials | |
| KR100860896B1 (en) | Bioabsorbable Wound Dressing | |
| CN115252280A (en) | Medical dressing | |
| JPH04303445A (en) | wound dressing | |
| US10137219B2 (en) | Coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating | |
| JPH05337151A (en) | Wound cover material | |
| CA2959946C (en) | A coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating | |
| JPH05192363A (en) | Wound covering material | |
| JPH05184661A (en) | Artificial skin | |
| JPH0751139B2 (en) | Wound dressing | |
| JP2852954B2 (en) | Artificial skin and method for producing the same | |
| JP2645098B2 (en) | Antibacterial agent-containing artificial skin and method for producing the same | |
| JPH0833672A (en) | Wound coating material | |
| JP2896216B2 (en) | Wound dressing | |
| JPH05337174A (en) | Cut covering material | |
| JP2892790B2 (en) | Adhesive dressing | |
| JPH04263855A (en) | Wound coating material | |
| JPH05285208A (en) | Dressing for surgery | |
| JPH0481466B2 (en) | ||
| JPH08126659A (en) | Base material for medical care containing antifungal material and wound covering material | |
| Reed | Mitraflex: development of an intelligent, spyrosorbent wound dressing | |
| JPS62183760A (en) | Wound cover material and its production | |
| JP2896210B2 (en) | Wound dressing | |
| JPS6048181B2 (en) | wound covering agent | |
| JPH04135563A (en) | Artificial skin |